The European ombudsman has called for the European Medicines Agency to grant access to clinical study reports and trial protocols …
Acomplia's EU suspension dispels illusion of blockbuster futureThe EMEA has suspended Acomplia due to the risk of serious psychiatric disorders. …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

